Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis
Peter J. Darlington(Concordia University), Amit Bar‐Or(University of Pennsylvania), Luis A. Solchaga(Case Western Reserve University), Jeffrey A. Cohen(Dartmouth Health), Marie‐Noëlle Boivin(Montreal Neurological Institute and Hospital), Christel Renoux(Jewish General Hospital), Jacques Galipeau(University of Wisconsin–Madison), Mark S. Freedman(University of Ottawa), Moïra François(Jewish General Hospital), Harold Atkins(University of Ottawa)
Cited by 80
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k
Multiple sclerosis
|Nature Reviews Disease Primers|2018|1.4k